Bridgebio Pharma, Inc.

BBIO·NASDAQ·$67.73Share Price as of 11/2·$13BMarket Cap as of 11/2

Financials

10-QQ3 ended 09/30/2610/29/26 10-QQ2 ended 06/30/2608/10/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/24/26 10-QQ3 ended 09/30/2510/29/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report10/13/26 8-KCurrent report08/31/26 8-KCurrent report08/17/26 8-KCurrent report08/10/26

Prospectuses and Registrations

424B7Prospectus08/14/26 S-3ASRAutomatic shelf registration07/24/26 S-8Registration of securities for employees07/24/26 S-3ASRAutomatic shelf registration05/08/26 S-8Registration of securities for employees08/05/25

Proxies

DEF 14ADefinitive proxy04/24/26 DEFA14AAdditional proxy materials04/24/26 DEFA14AAdditional proxy materials05/09/25 DEF 14ADefinitive proxy04/30/25 DEFA14AAdditional proxy materials04/30/25

Ownership

Form 4Insider transaction09/21/26 Form 4Insider transaction08/20/26 144Proposed sale of securities08/19/26 144Proposed sale of securities08/18/26 Form 4Insider transaction08/18/26

Other

ARSAnnual report to shareholders04/24/26 ARSAnnual report to shareholders04/30/25 ARSAnnual report to shareholders04/25/24 CT ORDERCT ORDER07/18/23 ARSAnnual report to shareholders04/28/23